Join Our Newsletter
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
A man with type 1 diabetes becomes the first to produce his own insulin after receiving gene-edited islet cell transplants — without immune-suppressing drugs. The breakthrough, published in the New England Journal of Medicine, could revolutionize diabetes treatment worldwide.
A new NEJM study shows that DB-OTO, a dual AAV1 gene therapy, restored natural hearing in 75% of children with otoferlin-related inherited deafness. This breakthrough could transform treatment for congenital hearing loss.